Cowen and Company’s Kensington Capital Acquisition Corp. IV Class 1 redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 KCAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-67,464
Closed -$20K 851
2022
Q2
$20K Buy
+67,464
New +$25.2K ﹤0.01% 398

Other funds holding KCAC.WS

Cowen and Company's KCAC.WS Position: Q3 2022 in Review

Cowen and Company sold out of Kensington Capital Acquisition Corp. IV Class 1 redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 (KCAC.WS) in Q3 2022, closing a stake of 67,464 shares — an estimated $20K sold.

Cowen and Company first reported a position in KCAC.WS in Q2 2022 and held it in 1 quarter. The position peaked at $20K in Q2 2022. 1 fund tracked by Wall St. Rank holds KCAC.WS as of Q3 2022.

  • Cowen and Company reported no remaining Kensington Capital Acquisition Corp. IV Class 1 redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Cowen and Company sold 67,464 Kensington Capital Acquisition Corp. IV Class 1 redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $20K.
  • Cowen and Company first reported a position in Kensington Capital Acquisition Corp. IV Class 1 redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2022 and held it in 1 quarter.
  • Cowen and Company's Kensington Capital Acquisition Corp. IV Class 1 redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $20K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Kensington Capital Acquisition Corp. IV Class 1 redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.